1hnagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and absence of diabetes. related antibodies. Osaka IDDM Study Group. N Engl J Med,2000,342: 301-307.
2American Diabetes Association. Diagnosis and classification of diabetes rnellitus. Diabetes Care ,2005,28 ( Suppl l ) : S37-42.
3Jmagawa A, Hanafusa T, Uchigata Y,et al. Fulminant type 1 diabetes -a nationwide survey in Japan. Diabetes Care,2003,26:2345-2352.
5Jung TS, Chung SI, Kim MA, et al. A Korean patient with Fulminant autaantibody-negative type 1 diabetes. Diabetes Care, 2004, 27: 3023 -3024.
6Taniyama M,Katsumata R,Aoki K,et al. A Filipino patient with fulminant type 1 diabetes. Diabetes Care,2004,27:842-843.
7Hanafusa T, lmagawaA. Fulminant type 1 diabetes:a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab ,2007,3:36-45.
8Nakamura T, Nagasaka S, Kusaka I, et al. HLA-DR-DQ haplotype in rapid-onset type 1 diabetes in Japanese. Diabetes Care, 2003,26: 1640-1641.
2Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Diabetes Care.1997,20:1183-1197.
3Tan KC,Mackay IR,Zimmet PZ,et al.Metabolic and immunologic features of Chinese patients with atypical diabetes melltitus.Diabetes Care,2000,23:335-338.
4Pinero-Pilona A,Litonjua P,Aviles-Santa L,et al.Idiopathic type 1 diabetes in Dallas,Texas.A 5-year experience.Diabetes Care,2001,24:1014-1018.
5Tiberti C,Buzzetti R,Anastasi E,et al.Autoantibody negative new onset type 1 diabetes lacking high risk HLA alleles in a Caucasian population :are these type lb diabetes cases? Diabetes Metab Res Rev,2000,16:8-14.
6Sabbah E,Savola K,Ebeling T,et al.Genetic,autoimmune,and clinical characteristics of childhood and adult-onset type 1diabetes.Diabetes Care,2000,23:1326-1332.
7Veijola R,Knip M,Reijonen H,et al.Effect of genetic risk load defined by HLA DQB1 polymorphism on clinical characteristics of IDDM in children.Eur J Clin Invest,1995,25:106-112.
8Imagawa A,Hanafusa T,Miyagawa J,et al.A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.N Engl J Med,2000,342:301-307.
9Imagawa A,Hanafusa T,Uchigata Y,et al.Fulminant type 1diabetes.A nationwide survey in Japan.Diabetes Care,2003,26:2345-2352.
10Pinero-Pilona A,Litonjua P.Idiopathic type 1 diabetes.J Diabetes Complications,2001,15:328-335.
2Imagawa A,Hanafusa T,Miyagawa J,et al.A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.Osaka IDDM Study Group[J].N Engl J Med,2000,342(5):301-307.
3Imagawa A,Hanafusa T,Awata T,et al.Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus:New diagnostic criteria of fulminant type 1 diabetes mellitus(2012)[J].J Diabetes Investig,2012,3(6):536-539.
4Imagawa A,Hanafusa T.Fulminant type 1 diabetes-an important subtype in East Asia[J].Diabetes Metab Res Rev,2011,27(8):959-964.
5Kim NH,Kim HY,Seo JA,et al.A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea:a comparison with a nationwide survey in Japan[J].Diabetes Res Clin Pract,2009,86(3):e43-e45.
6Luo S,Zhang Z,Li X,et al.Fulminant type 1 diabetes:a collaborative clinical cases investigation in China[J].Acta Diabetol,2013,50(1):53-59.
7Moreau C,Drui D,Arnault-Ouary G,et al.Fulminant type 1 diabetes in Caucasians:a report of three cases[J].Diabetes Metab,2008,34(5):529-532.
8Zheng C,Zhou Z,Yang L,et al.Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese[J].Diabetes Metab Res Rev,2011,27(1):70-78.
9Nakata S,Imagawa A,Miyata Y,et al.Low gene expression levels of activating receptors of natural killer cells(NKG2E and CD94) in patients with fulminant type 1 diabetes[J].Immunol Lett,2013,156(1/2):149-155.
10Endo T,Takizawa S,Tanaka S,et al.Amylase α-2A autoantibodies:novel marker of autoimmune pancreatitis and fulminant type 1 diabetes[J].Diabetes,2009,58(3):732-737.
